Characterizing the Histology Spatial Intersections Between Tumor-Infiltrating Lymphocytes and Tumors for Survival Prediction of Cancers Via Graph Contrastive Learning

被引:0
|
作者
Shi, Yangyang [1 ]
Zhu, Qi [1 ]
Zuo, Yingli [1 ]
Wan, Peng [1 ]
Zhang, Daoqiang [1 ]
Shao, Wei [1 ]
机构
[1] Nanjing Univ Aeronaut & Astronaut, Coll Comp Sci & Technol, MIIT Key Lab Pattern Anal & Machine Intelligence, Nanjing 211106, Peoples R China
关键词
Graph Contrastive Learning; Survival Analysis; Tumor-Infiltrating Lymphocytes; Whole-Slide Histopathological Image;
D O I
10.1007/978-3-031-73290-4_21
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Tumor-infiltrating lymphocytes (TILs) and their spatial interactions with tumors on whole-slide images (WSIs) of histopathology sections can provide valuable information about the immune response within the tumor micro-environment that is closely associated with the progression of human cancers. To effectively exploit the interactions between TILs and Tumors from WSIs, spatially informed analysis tools are required. Here, we present GCTIL, a simple but effective graph contrastive learning framework to learn meaningful representations for the TILs and tumor nodes extracted from the WSIs. Specifically, GCTIL considers the graph permutation of different strength to help learn robust node representations that can not only capture the structural characteristics of the graph but also preserve the correct distance orders among different permutations. Moreover, GCTIL also imposes distance constraints to distinguish the node embeddings of different types (i.e., TILs and Tumor). Then, based on the patch representation derived from GCTILs, we apply the graph attention networks (GATs) to describe the spatial interactions between TILs and tumor regions in WSIs for survival analysis of human cancers. We evaluate the performance of our method on the Breast Invasive Carcinoma (i.e., BRCA) cohort derived from The Cancer Genome Atlas (TCGA), and the experimental results indicate that our method is superior to the comparing methods.
引用
收藏
页码:212 / 221
页数:10
相关论文
共 50 条
  • [41] Relationship between Aldehyde Dehydrogenase, PD-L1 and Tumor-Infiltrating Lymphocytes with Pathologic Response and Survival in Breast Cancer
    Lopez Flores, Mariana
    Honrado Franco, Emiliano
    Sanchez Cousido, Luis Felipe
    Minguito-Carazo, Carlos
    Sanz Guadarrama, Oscar
    Lopez Gonzalez, Laura
    Vallejo Pascual, Maria Eva
    Molina de la Torre, Antonio Jose
    Garcia Palomo, Andres
    Lopez Gonzalez, Ana
    CANCERS, 2022, 14 (18)
  • [42] Novel deep learning-based survival prediction for oral cancer by analyzing tumor-infiltrating lymphocyte profiles through CIBERSORT
    Kim, Yeongjoo
    Kang, Ji Wan
    Kang, Junho
    Kwon, Eun Jung
    Ha, Mihyang
    Kim, Yoon Kyeong
    Lee, Hansong
    Rhee, Je-Keun
    Kim, Yun Hak
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [43] Computer extracted features related to the spatial arrangement of tumor-infiltrating lymphocytes predict overall survival in epithelial ovarian cancer receiving adjuvant chemotherapy
    Azarianpour, Sepideh
    Corredor, German
    Bera, Kaustav
    Leo, Patrick
    Braman, Nathaniel
    Fu, Pingfu
    Mahdi, Haider
    Madabhushi, Anant
    MEDICAL IMAGING 2020: DIGITAL PATHOLOGY, 2021, 11320
  • [44] Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study
    Cimino-Mathews, Ashley
    Ye, Xiaobu
    Meeker, Alan
    Argani, Pedram
    Emens, Leisha A.
    HUMAN PATHOLOGY, 2013, 44 (10) : 2055 - 2063
  • [45] Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502
    Stover, Daniel G.
    Salgado, Roberto
    Savenkov, Oleksander
    Ballman, Karla
    Mayer, Erica L.
    Magbanua, Mark Jesus M.
    Loi, Sherene
    Vater, Mark
    Glover, Kristyn
    Watson, Mark
    Wen, Yujia
    Symmans, W. Fraser
    Perou, Charles
    Carey, Lisa A.
    Partridge, Ann H.
    Rugo, Hope S.
    NPJ BREAST CANCER, 2024, 10 (01)
  • [46] Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti-PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival
    Ma, Kevin L.
    Mitchell, Tara C.
    Dougher, Meaghan
    Sharon, Cimarron E.
    Tortorello, Gabriella N.
    Elder, David E.
    Morgan, Eric E.
    Gimotty, Phyllis A.
    Huang, Alexander C.
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    Flowers, Ahron
    Miura, John T.
    Karakousis, Giorgos C.
    Xu, Xiaowei
    CLINICAL CANCER RESEARCH, 2024, 30 (21) : 4987 - 4994
  • [47] Spatial analysis of tumor infiltrating lymphocytes in histological images using deep learning predicts progression-free survival in colorectal cancer
    Xu, Hongming
    Cha, Yoon Jin
    Clemenceau, Jean
    Choi, Jinhwan
    Lee, Sung Hak
    Kang, Jeonghyun
    Hwang, Tae Hyun
    CANCER RESEARCH, 2022, 82 (12)
  • [48] Artificial intelligence (AI) -powered spatial analysis of tumor-infiltrating lymphocytes (TIL) for prediction of prognosis in stage II-III resectable colon cancer.
    Lim, Yoojoo
    Choi, Songji
    Oh, Hyeon Jeong
    Song, Sanghoon
    Kim, Sukjun
    Song, Heon
    Park, Seonwook
    Kim, Ji-Won
    Kim, Jin Won
    Kim, Jee Hyun
    Kang, Minsu
    Kang, Sung-Bum
    Kim, Duck-Woo
    Oh, Heung-Kwon
    Lee, Hye Seung
    Lee, Keun-Wook
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 211 - 211
  • [49] Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies
    Hida, Akira I.
    Sagara, Yasuaki
    Yotsumoto, Daisuke
    Kanemitsu, Shuichi
    Kawano, Junko
    Baba, Shinichi
    Rai, Yoshiaki
    Oshiro, Yumi
    Aogi, Kenjiro
    Sagara, Yoshiaki
    Ohi, Yasuyo
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) : 1 - 9
  • [50] Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies
    Akira I. Hida
    Yasuaki Sagara
    Daisuke Yotsumoto
    Shuichi Kanemitsu
    Junko Kawano
    Shinichi Baba
    Yoshiaki Rai
    Yumi Oshiro
    Kenjiro Aogi
    Yoshiaki Sagara
    Yasuyo Ohi
    Breast Cancer Research and Treatment, 2016, 158 : 1 - 9